Northwest Biotherapeutics (NWBO) EBT Growth (3y) (2013 - 2026)
Northwest Biotherapeutics (NWBO) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | 9.34% |
| 2 | Nanobiotix | 1,946.26 Bn | 1,946.20 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 473.25 Bn | 468.46 Bn | 1.35 Bn | 40.43% |
| 5 | Vertex Pharmaceuticals | 123.17 Bn | 115.92 Bn | 2.59 Bn | 12.01% |
| 6 | Regeneron Pharmaceuticals | 69.54 Bn | 60.79 Bn | 3.31 Bn | -1.05% |
| 7 | Belite Bio | 63.20 Bn | 63.20 Bn | - | - |
| 8 | Argenx Se | 56.91 Bn | 51.72 Bn | 1.41 Bn | 86.16% |
| 9 | Revolution Medicines | 38.23 Bn | 38.23 Bn | - | - |
| 10 | Northwest Biotherapeutics | 277.35 Mn | 275.56 Mn | - | 1.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.81% |
| Dec 31, 2025 | 6.05% |
| Sep 30, 2025 | 49.33% |
| Jun 30, 2025 | -3.18% |
| Mar 31, 2025 | -10.05% |
| Dec 31, 2024 | -30.40% |
| Sep 30, 2024 | -13.15% |
| Jun 30, 2024 | -13.19% |
| Mar 31, 2024 | 6.35% |
| Dec 31, 2023 | 16.25% |
| Sep 30, 2023 | 33.76% |
| Jun 30, 2023 | -19.88% |
| Mar 31, 2023 | -18.27% |
| Dec 31, 2022 | -59.07% |
| Sep 30, 2022 | -161.19% |
| Jun 30, 2022 | -44.78% |
| Mar 31, 2022 | -18.52% |
| Dec 31, 2021 | -58.21% |
| Sep 30, 2021 | -2.20% |
| Jun 30, 2021 | 17.64% |